Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dynamics of saccade parameters in multiple sclerosis patients with fatigue.
Axonal Loss in a Rat Model of Optic Neuritis Is Closely Correlated with Visual Evoked Potential Amplitudes Using Electroencephalogram-based Scaling.
Neuroprotection With Riluzole Patients With Early Multiple Sclerosis
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient.
The effect of gabapentin on oxidative stress in a model of toxic demyelination in rat brain.
Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis.
The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects.
A cluster randomised controlled trial on the efficacy of client-centred occupational therapy in multiple sclerosis: good process, poor outcome.
Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein.
Nogo-A: Multiple Roles in CNS Development, Maintenance, and Disease.
Compressive syndrome of internal jugular veins in multiple sclerosis: does it matter?
Integrin/Chemokine Receptor Interactions in the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.
Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients.
Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension.
Decreased urinary level of melatonin as a marker of disease severity in patients with multiple sclerosis.
dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis.
Central nervous system myeloid cells as drug targets: current status and translational challenges.
TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis.
Neuroprotection in Huntington's disease: a 2-year study on minocycline.
The relation between peptide hormones and sex hormone in patients with multiple sclerosis.
Brain imaging and bladder function.
The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up.
Mesenchymal Stem Cell treatment for autoimmune diseases: a critical review.
Low dose naltrexone for induction of remission in Crohn's disease.

Pages